Skip to main content

Day: March 7, 2024

Quanex Building Products Announces First Quarter 2024 Results and Provides Full Year 2024 Guidance

Margin Expansion on a Consolidated Basis Repaid $5 Million in Bank Debt Balance Sheet and Liquidity Remain Strong Cautiously Optimistic on Second Half of 2024 Positive Long-Term View on Residential Housing Market Remains Intact HOUSTON, March 07, 2024 (GLOBE NEWSWIRE) —  Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended January 31, 2024.   The Company reported the following selected financial results:      Three Months Ended January 31,($ in millions, except per share data)     2024   2023Net Sales     $239.2   $261.9Gross Margin     $51.4   $51.8Gross Margin %     21.5%   19.8%Net Income     $6.2   $1.9Diluted EPS     $0.19   $0.06           Adjusted Net Income     $5.8   $6.1Adjusted Diluted EPS     $0.18   $0.18Adjusted...

Continue reading

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Financial HighlightsFourth Quarter Ended December 31, 2023Net revenue from continuing operations was $3.3 million, compared to $2.6 million in the fourth quarter of 2022, up 27% Net loss from continuing operations was ($0.7 million), approximately equal to the same period in 2022 Adjusted EBITDA from continuing operations was ($0.1 million), compared to ($0.5 million) in the fourth quarter of 2022, an improvement of 89%Year-End 2023Net revenue...

Continue reading

VALHI REPORTS FOURTH QUARTER 2023 RESULTS

Dallas, Texas, March 07, 2024 (GLOBE NEWSWIRE) — Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $3.9 million, or $.14 per share, in the fourth quarter of 2023 compared to a net loss of $9.4 million, or $.33 per share, in the fourth quarter of 2022. For the full year of 2023, Valhi reported a net loss attributable to Valhi stockholders of $12.1 million, or $.42 per share, compared to net income of $90.2 million, or $3.16 per share, for the full year of 2022. Net income attributable to Valhi stockholders increased in the fourth quarter of 2023 as compared to the fourth quarter of 2022 primarily due to higher operating results from all of our segments. Net income attributable to Valhi stockholders decreased in the full year of 2023 as compared to the full year of 2022 primarily due to lower operating...

Continue reading

HCI Group Reports Fourth Quarter and Full Year 2023 Results

Fourth Quarter Diluted EPS of $3.40Fourth Quarter Gross Loss Ratio of 30.4%Fourth Quarter Pre-Tax Income of $54.2 million TAMPA, Fla., March 07, 2024 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), a holding company with operations in homeowners insurance, information technology services, real estate, and reinsurance, reported pre-tax income of $54.2 million and net income of $40.9 million, or $3.40 diluted earnings per share, in the fourth quarter of 2023, compared with net income of $2.7 million, or $0.18 diluted earnings per share, in the fourth quarter of 2022. Adjusted net income (a non-GAAP measure which excludes net unrealized gains or losses on equity securities) for the fourth quarter of 2023 was $38.8 million, or $3.22 diluted earnings per share compared with adjusted net income of $1.6 million, or $0.06 diluted earnings...

Continue reading

Costco Wholesale Corporation Reports Second Quarter and Year-to-Date Operating Results for Fiscal 2024 and February Sales Results

ISSAQUAH, Wash., March 07, 2024 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the second quarter (twelve weeks) and the first 24 weeks of fiscal 2024, ended February 18, 2024. Net sales for the quarter increased 5.7 percent, to $57.33 billion, from $54.24 billion last year. Net sales for the first 24 weeks increased 5.9 percent, to $114.05 billion, from $107.68 billion last year. Net sales for the Company were negatively impacted by approximately one and one-half percent for the quarter and by approximately one-half percent for the first 24 weeks of fiscal 2024 from the shift of the fiscal calendar, as a result of the fifty-third week last year. The following comparable sales data reflect comparable locations year-over-year and comparable retail...

Continue reading

Gulf Island Reports Fourth Quarter and Full Year 2023 Results

THE WOODLANDS, Texas, March 07, 2024 (GLOBE NEWSWIRE) — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the industrial and energy sectors, today announced results for the fourth quarter and full year 2023. FOURTH QUARTER 2023 SUMMARYConsolidated revenue of $44.6 million Consolidated net income of $7.1 million; Adjusted EBITDA of $6.6 million Services Division operating income of $2.7 million; EBITDA of $3.2 million Fabrication Division operating income of $6.1 million; Adjusted EBITDA of $5.4 million Cash and short-term investments balance of $47.9 million at December 31, 2023 Substantially completed remaining ferry projects for the Shipyard DivisionConsolidated revenue for the fourth quarter 2023 was $44.6 million, compared to consolidated revenue...

Continue reading

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

MOUNTAIN VIEW, Calif., March 07, 2024 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced its financial results for the fourth quarter and full year ended December 31, 2023 and provided an update on recent developments. “We made significant progress during 2023 in the clinical development of our two lead product candidates in therapeutic areas that we believe have the greatest potential to produce significant near-term value,” said Fred Schwarzer, Chief Executive Officer of IGM Biosciences. “Enrollment in our randomized clinical trial of aplitabart plus FOLFIRI and bevacizumab in second-line metastatic colorectal cancer continues to be encouraging, and we expect to expeditiously complete our target enrollment of 110 patients....

Continue reading

Runway Growth Finance Corp. Reports Fourth Quarter and Fiscal Year Ended 2023 Financial Results

Delivered Total and Net Investment Income of $39.2 million and $18.3 million, Respectively Investment Portfolio of $1.0 billion Conference Call Today, Thursday, March 7, 2024 at 5:00 p.m. ET MENLO PARK, Calif., March 07, 2024 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 HighlightsTotal investment income of $39.2 million Net investment income of $18.3 million, or $0.45 per share Net asset value of $13.50 per share Dollar-weighted annualized yield on debt investments of 16.9% for the quarter Eight investments completed in new and existing...

Continue reading

Oil-Dri Achieves Record Results for the Second Quarter and Triples its Net Income

CHICAGO, March 07, 2024 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its second quarter and first six-months of fiscal year 2024.  Second Quarter Year to Date(in thousands, except per share amounts) Ended January 31, Ended January 31,  2024 2023 Change 2024 2023 ChangeConsolidated Results            Net Sales $ 105,668 $ 101,669 4% $ 217,106 $ 200,208 8%Net Income Attributable to Oil-Dri $   12,382 $     3,856 221% $   23,124 $     9,097 154%Net Income Attributable to Oil-Dri Excluding Nonrecurring Events † $   12,844 $     5,833 120% $   23,586 $   11,074 113%Diluted EPS – Common $       1.70 $       0.56 204% $       3.19 $       1.34 138%Diluted EPS – Common, Excluding Nonrecurring Events...

Continue reading

Noodles & Company Announces Fourth Quarter and Full Year 2023 Financial Results

BROOMFIELD, Colo., March 07, 2024 (GLOBE NEWSWIRE) — Noodles & Company (Nasdaq: NDLS) today announced financial results for the fourth quarter and fiscal year ended January 2, 2024, and provided a 2024 business outlook. Key highlights for the fourth quarter of 2023 (13 weeks) compared to the fourth quarter of 2022 (14 weeks) include:Total revenue decreased 8.9% to $124.3 million from $136.5 million. Adjusting for the impact of the 53rd week in the fourth quarter of 2022, total revenue decreased $3.1 million in the fourth quarter of 2023, or 2.4%. Comparable restaurant sales decreased 4.2% system-wide, including a 4.3% decrease for company-owned restaurants and a 3.6% decrease for franchise restaurants. Net loss was $6.1 million, or $0.14 loss per diluted share, compared to net income of $1.0 million, or $0.02 per diluted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.